[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@AppieAnanas "$PRQR Oct investor conferences may quietly preview new Axiomer CNS data (AX-0810 / Rett). Some slides likely overlap with Eli Lilly-linked targets under NDA shared only with institutions. What do you think Theres something bubbling anyway"
X Link @AppieAnanas 2025-10-14T12:42Z XX followers, XXX engagements

"3/ If these are co-owned IP assets $PRQR could earn royalties on multiple Eli Lilly programs adding real long-term cash flow potential. Even a XX% royalty stream on several CNS or metabolic drugs could be worth hundreds of millions over time"
X Link @AppieAnanas 2025-10-10T07:35Z XX followers, XXX engagements

"@SelsoftDataFlow If ProQRs Rett NHP data confirm safe and efficient CNS RNA editing Eli Lilly gains a strong incentive to acquire not just partner to lock down the Axiomer platform and accelerate its own neuro pipeline. $PRQR"
X Link @AppieAnanas 2025-10-15T15:21Z XX followers, XXX engagements

"@SelsoftDataFlow X is a nice rest stop on the climb to the top if everything goes well"
X Link @AppieAnanas 2025-10-15T15:02Z XX followers, XX engagements

"$PRQR closed strong at $XXXX (+10.16%) followed by 1.4M shares traded after hours nearly X avg daily volume. No news no hype just quiet accumulation ahead of key near-term catalysts: - AX-0810 trial start / CTA approval - CNS program visibility - Fall investor event"
X Link @AppieAnanas 2025-10-15T20:52Z XX followers, XXX engagements